Natus Medical Price on September 15, 2017 Breakdown

BABY -- USA Stock  

USD 35.50  0.55  1.53%

Use Natus Medical Incorporated price on September 15, 2017 together with your stock portfolios to protect against small markets fluctuations and to determine Stock optimization strategy that fits your criteria.  

Natus Medical Valuation Near September 15, 2017

 Open High Low Close Volume
  35.30    36.00    34.95    35.60    419,920  
 09/15/2017 
  35.70    35.70    35.05    35.10    285,194  
  35.25    35.40    34.95    35.25    276,176  
Backtest Natus Medical  |  Natus Medical History  |  Natus Medical Valuation   PreviousNext  
September 15, 2017
35.7
Open Value
 
35.1
Closing Value
Target Odds
  
41.95
Upside
 

Natus Medical Trading Date Momentum on September 15, 2017

On September 18 2017 Natus Medical Incorporated was traded for 35.25  at the closing time. The top price for the day was 35.40  and the lowest listed price was  34.95 . The trading volume for the day was 276.2 K. The trading history from September 18, 2017 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 0.43% . The trading delta at closing time against the current closing price is 0.14% .

Natus Medical Incorp Fundamentals Correlations and Trends

Did you try this?

Run Piotroski F Score Now
   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Piotroski F Score

Price Boundaries

Natus Medical Period Price Range
Low
September 15, 2017
High
 35.70 
  
 35.10 
0.6  1.68%

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Check also Trending Equities. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.